These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ocular melanosis with special reference to chlorpromazine. Cameron ME Br J Ophthalmol; 1967 May; 51(5):295-305. PubMed ID: 6022771 [No Abstract] [Full Text] [Related]
5. Black cornea: a complication of topical use of epinephrine. Green WR; Kaufer GJ; Dubroff S Ophthalmologica; 1967; 154(2):88-95. PubMed ID: 6057543 [No Abstract] [Full Text] [Related]
6. [Corneal pigmentation from epinephrine bitartrate]. Calmettes L; Deodati F; Bechac G Arch Ophtalmol Rev Gen Ophtalmol; 1968; 28(3):303-5. PubMed ID: 4233893 [No Abstract] [Full Text] [Related]
7. Pemphigoid related to epinephrine treatment. Hoffer KJ Am J Ophthalmol; 1977 Apr; 83(4):601. PubMed ID: 868961 [No Abstract] [Full Text] [Related]
8. Low dosage combined adrenaline-guanethidine formulations in the management of chronic simple glaucoma. Jones DE; Norton DA; Davies DJ Trans Ophthalmol Soc U K (1962); 1977 Apr; 97(1):192-5. PubMed ID: 339412 [No Abstract] [Full Text] [Related]
10. Incidence of late "melanosis" side effects in chronic mental patients after long term phenothiazine therapy. Forrest FM; Snow HL; Erickson G; Geiter CW; Laxson GO Proc West Pharmacol Soc; 1966; 9():18-20. PubMed ID: 5958492 [No Abstract] [Full Text] [Related]
11. External side-effects by Eppy. Spiers F; Eldruf-Jorgensen P Trans Ophthalmol Soc U K (1962); 1966; 86():255-60. PubMed ID: 5226578 [No Abstract] [Full Text] [Related]
12. [Adrenochrome conjunctival inclusions following a local adrenaline therapy (author's transl)]. Schmitt H; Remler O Klin Monbl Augenheilkd; 1974 Aug; 165(2):332-6. PubMed ID: 4215920 [No Abstract] [Full Text] [Related]
13. Obstruction of lacrimal puncta caused by topical epinephrine. Romano A; Barishak R; Stein R Ophthalmologica; 1973; 166(4):301-5. PubMed ID: 4709370 [No Abstract] [Full Text] [Related]
15. Ocular and cutaneous effects of chronic phenothiazine therapy. Bond WS; Yee GC Am J Hosp Pharm; 1980 Jan; 37(1):74-8. PubMed ID: 6102438 [No Abstract] [Full Text] [Related]
16. Prolonged treatment of psychotic states. (Over 1600 patients treated continuously 3 to 7 years). Goldman D Dis Nerv Syst; 1968 Mar; 29(3):Suppl:51-7. PubMed ID: 4970486 [No Abstract] [Full Text] [Related]
17. Squamous metaplasia or epidermalization of the conjunctiva as an adverse reaction to topical medication. Wright P Trans Ophthalmol Soc U K (1962); 1979 Jul; 99(2):244-6. PubMed ID: 298421 [TBL] [Abstract][Full Text] [Related]
18. [About a rare side effect of epinephrine eye drops (author's transl)]. Schuster H Klin Monbl Augenheilkd; 1974 Sep; 165(3):517-9. PubMed ID: 4437040 [No Abstract] [Full Text] [Related]
19. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost. Chiba T; Kashiwagi K; Ishijima K; Furuichi M; Kogure S; Abe K; Chiba N; Tsukahara S Jpn J Ophthalmol; 2004; 48(2):141-7. PubMed ID: 15060793 [TBL] [Abstract][Full Text] [Related]
20. Pemphigoid related to epinephrine treatment. Norn MS Am J Ophthalmol; 1977 Jan; 83(1):138. PubMed ID: 319673 [No Abstract] [Full Text] [Related] [Next] [New Search]